Positive Co-operative Binding at Two Weak Lysine-binding Sites Governs the Glu-plasminogen Conformational Change
Overview
Authors
Affiliations
The kinetics of a series of Glu-plasminogen ligand-binding processes were investigated at pH 7.8 and 25 degrees C (in 0.1 M-NaCl). The ligands include compounds analogous to C-terminal lysine residues and to normal lysine residues. Changes of the Glu-plasminogen protein fluorescence were measured in a stopped-flow instrument as a function of time after rapid mixing of Glu-plasminogen and ligand at various concentrations. Large positive fluorescence changes (approximately 10%) accompany the ligand-induced conformational changes of Glu-plasminogen resulting from binding at weak lysine-binding sites. Detailed studies of the concentration-dependencies of the equilibrium signals and the rate constants of the process induced by various ligands showed the conformational change to involve two sites in a concerted positive co-operative process with three steps: (i) binding of a ligand at a very weak lysine-binding site that preferentially, but not exclusively, binds C-terminal-type lysine ligands, (ii) the rate-determining actual-conformational-change step and (iii) binding of one more lysine ligand at a second weak lysine-binding site that then binds the ligand more tightly. Further, totally independent initial small negative fluorescence changes (approximately 2-4%) corresponding to binding at the strong lysine-binding site of kringle 1 [Sottrup-Jensen, Claeys, Zajdel, Petersen & Magnusson (1978) Prog. Chem. Fibrinolysis Thrombolysis 3, 191-209] were observed for the C-terminal-type ligands. The finding that the conformational change in Glu-plasminogen involves two weak lysine-binding sites indicates that the effect cannot be assigned to any single kringle and that the problem of whether kringle 4 or kringle 5 is responsible for the process resolves itself. Probably kringle 4 and 5 are both participating. The involvement of two lysine binding-sites further makes the high specificity of Glu-plasminogen effectors more conceivable.
Quek A, Cowieson N, Caradoc-Davies T, Conroy P, Whisstock J, Law R Int J Mol Sci. 2023; 24(18).
PMID: 37762561 PMC: 10531915. DOI: 10.3390/ijms241814258.
Coppolino F, Romeo L, Pietrocola G, Lentini G, De Gaetano G, Teti G Front Cell Infect Microbiol. 2021; 11:679792.
PMID: 34568085 PMC: 8455988. DOI: 10.3389/fcimb.2021.679792.
Herman-Bausier P, Pietrocola G, Foster T, Speziale P, Dufrene Y mBio. 2017; 8(5).
PMID: 28874469 PMC: 5587908. DOI: 10.1128/mBio.01067-17.
Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes.
Huish S, Thelwell C, Longstaff C PLoS One. 2017; 12(1):e0170936.
PMID: 28125743 PMC: 5268773. DOI: 10.1371/journal.pone.0170936.
Pietrocola G, Nobile G, Gianotti V, Zapotoczna M, Foster T, Geoghegan J J Biol Chem. 2016; 291(35):18148-62.
PMID: 27387503 PMC: 5000064. DOI: 10.1074/jbc.M116.731125.